You are currently on the new version of our website. Access the old version .

107 Results Found

  • Review
  • Open Access
34 Citations
10,080 Views
20 Pages

The Multiple Facets of ATRX Protein

  • Martina Valenzuela,
  • Roberta Amato,
  • Antonella Sgura,
  • Antonio Antoccia and
  • Francesco Berardinelli

5 May 2021

ATRX gene codifies for a protein member of the SWI-SNF family and was cloned for the first time over 25 years ago as the gene responsible for a rare developmental disorder characterized by α-thalassemia and intellectual disability called Alpha Thalas...

  • Article
  • Open Access
6 Citations
4,306 Views
20 Pages

Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour

  • Tiago Bordeira Gaspar,
  • Sofia Macedo,
  • Ana Sá,
  • Mariana Alves Soares,
  • Daniela Ferreira Rodrigues,
  • Mafalda Sousa,
  • Nuno Mendes,
  • Rui Sousa Martins,
  • Luís Cardoso and
  • João Vinagre
  • + 6 authors

10 August 2022

ATRX is a chromatin remodeller that maintains telomere homeostasis. Loss of ATRX is described in approximately 10% of pancreatic neuroendocrine tumours (PanNETs) and associated with poorer prognostic features. Here, we present a genetically engineere...

  • Review
  • Open Access
32 Citations
8,197 Views
22 Pages

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer

  • Ying Pang,
  • Xu Chen,
  • Tongjie Ji,
  • Meng Cheng,
  • Rui Wang,
  • Chunyu Zhang,
  • Min Liu,
  • Jing Zhang and
  • Chunlong Zhong

10 April 2023

The alpha-thalassemia mental retardation X-linked (ATRX) syndrome protein is a chromatin remodeling protein that primarily promotes the deposit of H3.3 histone variants in the telomere area. ATRX mutations not only cause ATRX syndrome but also influe...

  • Article
  • Open Access
2,167 Views
19 Pages

Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption

  • Tiago Bordeira Gaspar,
  • Tito Teles Jesus,
  • Maria Teresa Azevedo,
  • Sofia Macedo,
  • Mariana Alves Soares,
  • Rui Sousa Martins,
  • Rúben Leite,
  • Lia Rodrigues,
  • Daniela Ferreira Rodrigues and
  • João Vinagre
  • + 6 authors

1 June 2023

Atrx loss was recently ascertained as insufficient to drive pancreatic neuroendocrine tumour (PanNET) formation in mice islets. We have identified a preponderant role of Atrx in the endocrine dysfunction in a Rip-Cre;AtrxKO genetically engineered mou...

  • Review
  • Open Access
16 Citations
6,077 Views
15 Pages

ATRX/DAXX: Guarding the Genome against the Hazards of ALT

  • Sarah F. Clatterbuck Soper and
  • Paul S. Meltzer

24 March 2023

Proliferating cells must enact a telomere maintenance mechanism to ensure genomic stability. In a subset of tumors, telomeres are maintained not by telomerase, but through a homologous recombination-based mechanism termed Alternative Lengthening of T...

  • Article
  • Open Access
25 Citations
8,253 Views
28 Pages

ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation

  • Domenico Marano,
  • Salvatore Fioriniello,
  • Francesca Fiorillo,
  • Richard J. Gibbons,
  • Maurizio D’Esposito and
  • Floriana Della Ragione

29 October 2019

Methyl-CpG binding protein 2 (MeCP2) is a multi-function factor involved in locus-specific transcriptional modulation and the regulation of genome architecture, e.g., pericentric heterochromatin (PCH) organization. MECP2 mutations are responsible for...

  • Review
  • Open Access
1 Citations
2,708 Views
21 Pages

18 November 2023

The Drosophila melanogaster dADD1 and dXNP proteins are orthologues of the ADD and SNF2 domains of the vertebrate ATRX (Alpha-Thalassemia with mental Retardation X-related) protein. ATRX plays a role in general molecular processes, such as regulating...

  • Article
  • Open Access
15 Citations
4,259 Views
19 Pages

ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas

  • Lucie Darmusey,
  • Gaëlle Pérot,
  • Noémie Thébault,
  • Sophie Le Guellec,
  • Nelly Desplat,
  • Laëtitia Gaston,
  • Lucile Delespaul,
  • Tom Lesluyes,
  • Elodie Darbo and
  • Frédéric Chibon
  • + 5 authors

29 April 2021

Whole genome and transcriptome sequencing of a cohort of 67 leiomyosarcomas has been revealed ATRX to be one of the most frequently mutated genes in leiomyosarcomas after TP53 and RB1. While its function is well described in the alternative lengtheni...

  • Review
  • Open Access
76 Citations
12,949 Views
20 Pages

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype

  • João P. Amorim,
  • Gustavo Santos,
  • João Vinagre and
  • Paula Soares

19 September 2016

Telomeres are responsible for protecting chromosome ends in order to prevent the loss of coding DNA. Their maintenance is required for achieving immortality by neoplastic cells and can occur by upregulation of the telomerase enzyme or through a homol...

  • Article
  • Open Access
14 Citations
3,309 Views
19 Pages

Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma

  • Vania Balderrama Brondani,
  • Amanda Meneses Ferreira Lacombe,
  • Beatriz Marinho de Paula Mariani,
  • Luciana Montenegro,
  • Iberê Cauduro Soares,
  • João Evangelista Bezerra-Neto,
  • Fabio Yoshiaki Tanno,
  • Victor Srougi,
  • José Luis Chambo and
  • Maria Candida Barisson Villares Fragoso
  • + 2 authors

27 January 2021

Adrenocortical carcinoma (ACC) is a rare malignancy that is associated with a dismal prognosis. Pan-genomic studies have demonstrated the involvement of ATRX and ZNRF3 genes in adrenocortical tumorigenesis. Our aims were to evaluate the protein expre...

  • Article
  • Open Access
8 Citations
5,029 Views
17 Pages

ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors

  • David Pladevall-Morera,
  • María Castejón-Griñán,
  • Paula Aguilera,
  • Karina Gaardahl,
  • Andreas Ingham,
  • Jacqueline A. Brosnan-Cashman,
  • Alan K. Meeker and
  • Andres J. Lopez-Contreras

31 March 2022

High-grade glioma, including anaplastic astrocytoma and glioblastoma (GBM) patients, have a poor prognosis due to the lack of effective treatments. Therefore, the development of new therapeutic strategies to treat these gliomas is urgently required....

  • Article
  • Open Access
1,526 Views
24 Pages

27 August 2025

Herpes simplex virus 1 (HSV-1) transcribes its genome using host RNA polymerase II (Pol II) in a temporally regulated cascade. We previously proposed a model of Transient Immediate Early gene Mediated Repression (TIEMR), in which early repression of...

  • Article
  • Open Access
13 Citations
1,934 Views
13 Pages

Comparison of MRI Sequences to Predict ATRX Status Using Radiomics-Based Machine Learning

  • Nabila Gala Nacul Mora,
  • Burak Han Akkurt,
  • Dilek Kasap,
  • David Blömer,
  • Walter Heindel,
  • Manoj Mannil and
  • Manfred Musigmann

ATRX is an important molecular marker according to the 2021 WHO classification of adult-type diffuse glioma. We aim to predict the ATRX mutation status non-invasively using radiomics-based machine learning models on MRI and to determine which MRI seq...

  • Article
  • Open Access
646 Views
18 Pages

DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Immunohistochemistry—A Digital Quantitative Pilot Study

  • Annika Spitzer,
  • Heike Aupperle-Lellbach,
  • Martin Spitzer,
  • Silvia Weidle,
  • Leonore Aeschlimann,
  • Joshua Schwinn,
  • Robert Klopfleisch and
  • Simone de Brot

17 December 2025

The chromatin remodelling proteins DAXX and ATRX are key regulators of genome stability and epigenetic processes. Alterations in their expression have been associated with tumour stage and prognostic outcomes in various human cancer types, whereas th...

  • Article
  • Open Access
1 Citations
1,875 Views
13 Pages

19 December 2023

The chromatin-remodeling protein ATRX, which is currently recognized as one of the key genome caretakers, plays an important role in oogenesis and early embryogenesis in mammals. ATRX distribution in the nuclei of mouse embryos developing in vivo and...

  • Article
  • Open Access
14 Citations
4,218 Views
15 Pages

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

  • Ming Yuan,
  • Charles G. Eberhart,
  • Christine A. Pratilas,
  • Jaishri O. Blakeley,
  • Christine Davis,
  • Marija Stojanova,
  • Karlyne Reilly,
  • Alan K. Meeker,
  • Christopher M. Heaphy and
  • Fausto J. Rodriguez

19 June 2022

Subsets of Neurofibromatosis Type 1 (NF1)-associated solid tumors have been shown to display high frequencies of ATRX mutations and the presence of alternative lengthening of telomeres (ALT). We studied the phenotype of combined NF1 and ATRX deficien...

  • Review
  • Open Access
41 Citations
8,451 Views
21 Pages

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma

  • Hueng-Chuen Fan,
  • Chuan-Mu Chen,
  • Ching-Shiang Chi,
  • Jeng-Dau Tsai,
  • Kuo-Liang Chiang,
  • Yu-Kang Chang,
  • Shinn-Zong Lin and
  • Horng-Jyh Harn

Glioblastoma multiforme (GBM) is a type of brain tumor that is notorious for its aggressiveness and invasiveness, and the complete removal of GBM is still not possible, even with advanced diagnostic strategies and extensive therapeutic plans. Its dis...

  • Article
  • Open Access
5 Citations
2,866 Views
19 Pages

Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes

  • Anna Djos,
  • Ketan Thombare,
  • Roshan Vaid,
  • Jennie Gaarder,
  • Ganesh Umapathy,
  • Susanne E. Reinsbach,
  • Kleopatra Georgantzi,
  • Jakob Stenman,
  • Helena Carén and
  • Susanne Fransson
  • + 3 authors

7 December 2023

Tumor cells are hallmarked by their capacity to undergo unlimited cell divisions, commonly accomplished either by mechanisms that activate TERT or through the alternative lengthening of telomeres pathway. Neuroblastoma is a heterogeneous pediatric ca...

  • Article
  • Open Access
7 Citations
3,491 Views
17 Pages

ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN

  • Jian-Ching Wu,
  • Chao-Cheng Huang,
  • Pei-Wen Wang,
  • Ting-Ya Chen,
  • Wen-Ming Hsu,
  • Jiin-Haur Chuang and
  • Hui-Ching Chuang

13 January 2023

Neuroblastoma (NB) is characterized by several malignant phenotypes that are difficult to treat effectively without combination therapy. The therapeutic implication of mitochondrial ClpXP protease ClpP and ClpX has been verified in several malignanci...

  • Article
  • Open Access
6 Citations
4,950 Views
9 Pages

Phenotypic Spectrum and Molecular Findings in 17 ATR-X Syndrome Italian Patients: Some New Insights

  • Alessandro Vaisfeld,
  • Sara Taormina,
  • Alessandro Simonati and
  • Giovanni Neri

4 October 2022

ATR-X syndrome is a rare X-linked congenital disorder caused by hypomorphic mutations in the ATRX gene. A typical phenotype is well defined, with cognitive impairment, characteristic facial dysmorphism, hypotonia, gastrointestinal, skeletal, urogenit...

  • Article
  • Open Access
5 Citations
1,847 Views
14 Pages

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma

  • Jolique A. van Ipenburg,
  • Quincy C. C. van den Bosch,
  • Dion Paridaens,
  • Hendrikus J. Dubbink,
  • Emine Kiliç,
  • Nicole Naus and
  • Robert M. Verdijk

20 August 2023

Metastatic disease is linked to TERT promoter mutations in conjunctival melanomas (CM). Both TERT promoter and ATRX mutations are associated with faulty telomere maintenance. This study aimed to determine the prognostic value of ATRX loss in conjunct...

  • Article
  • Open Access
1 Citations
3,786 Views
19 Pages

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma

  • Faris Durmo,
  • Jimmy Lätt,
  • Anna Rydelius,
  • Elisabet Englund,
  • Tim Salomonsson,
  • Patrick Liebig,
  • Johan Bengzon,
  • Peter C. M. van Zijl,
  • Linda Knutsson and
  • Pia C. Sundgren

Objectives: To assess amide proton transfer weighted (APTw) MR imaging capabilities in differentiating high-grade glial tumors across alpha-thalassemia/mental retardation X-linked (ATRX) expression, tumor-suppressor protein p53 expression (p53), O6-m...

  • Article
  • Open Access
19 Citations
4,652 Views
15 Pages

18 September 2018

α-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in ATRX. An ATR-X model mouse lacking Atrx exon 2 displays phenotypes that resemble symptoms in the human intellectual disability: cognitive defects and abno...

  • Article
  • Open Access
2 Citations
2,533 Views
14 Pages

During carcinogenesis, cells must acquire a telomere maintenance mechanism in order to avoid telomere shortening-induced replicative senescence. While most tumors activate telomerase, a minority of them employ a recombinational mechanism called Alter...

  • Article
  • Open Access
1,474 Views
17 Pages

ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance

  • Andrea Pop-Crisan,
  • Radu Pirlog,
  • Lavinia-Lorena Pruteanu,
  • Constantin Busuioc,
  • Ovidiu-Laurean Pop,
  • Deo Prakash Pandey,
  • Cornelia Braicu and
  • Ioana Berindan-Neagoe

10 April 2025

Background and Objectives: Glioblastoma (GBM) is among the most aggressive and lethal primary brain tumors, characterized by high heterogeneity, invasive growth, and resistance to conventional therapies. The 2021 WHO classification highlights the imp...

  • Article
  • Open Access
1,164 Views
12 Pages

Hemoglobin Disorders Associated with Neurological Impairment: First Report of ATR-X Syndrome and Recessive Congenital Methemoglobinemia Type II in Tunisia

  • Houyem Ouragini,
  • Emna Bouatrous,
  • Manel Kasdallah,
  • Sonia Nouira,
  • Hamza Dallali,
  • Samia Rekaya,
  • Dorra Chaouachi,
  • Monia Ouederni and
  • Samia Menif

Hemoglobin disorders are among the most common inherited diseases worldwide. Their clinical manifestations range from anemia to more severe forms associated with neurological impairments. These complications can result as secondary consequences of th...

  • Article
  • Open Access
6 Citations
2,619 Views
13 Pages

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67

  • Tamás-Csaba Sipos,
  • Attila Kövecsi,
  • Șușu Ovidiu-Ioan and
  • Pap Zsuzsánna

30 October 2023

Introduction: A glioblastoma is an intra-axial brain tumour of glial origin that belongs to the category of diffuse gliomas and is the most common malignant neoplasia of the central nervous system. The rate of survival at 5 years, from the moment of...

  • Review
  • Open Access
8 Citations
3,428 Views
17 Pages

13 September 2022

Current knowledge on the molecular landscape of pancreatic neuroendocrine tumors (PanNETs) has advanced significantly. Still, the cellular origin of PanNETs is uncertain and the associated mechanisms remain largely unknown. DAXX/ATRX and MEN1 are the...

  • Article
  • Open Access
1,858 Views
14 Pages

4 September 2025

Background/Objectives: Astrocytoma, IDH-mutant, CNS WHO grade 3, is a diffuse glioma with poor prognosis, molecularly defined by IDH mutations and frequently co-occurring TP53 and ATRX alterations. This study aimed to delineate the genomic landscape...

  • Article
  • Open Access
2 Citations
1,672 Views
17 Pages

Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas

  • Tamás-Csaba Sipos,
  • Kövecsi Attila,
  • Lóránd Kocsis,
  • Adrian Bălașa,
  • Rareș Chinezu,
  • Beáta Ágota Baróti and
  • Zsuzsánna Pap

4 December 2024

Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (...

  • Review
  • Open Access
14 Citations
4,635 Views
12 Pages

28 January 2021

The Death-domain associated protein 6 (DAXX) is an evolutionarily conserved and ubiquitously expressed multifunctional protein that is implicated in many cellular processes, including transcription, cellular proliferation, cell cycle regulation, Fas-...

  • Article
  • Open Access
20 Citations
5,207 Views
22 Pages

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma

  • María Monteagudo,
  • Paula Martínez,
  • Luis J. Leandro-García,
  • Ángel M. Martínez-Montes,
  • Bruna Calsina,
  • Marta Pulgarín-Alfaro,
  • Alberto Díaz-Talavera,
  • Sara Mellid,
  • Rocío Letón and
  • Mercedes Robledo
  • + 27 authors

23 September 2021

One of the main problems we face with PPGL is the lack of molecular markers capable of predicting the development of metastases in patients. Telomere-related genes, such as TERT and ATRX, have been recently described in PPGL, supporting the associati...

  • Article
  • Open Access
17 Citations
4,037 Views
14 Pages

Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR

  • Maurizio Salvati,
  • Placido Bruzzaniti,
  • Michela Relucenti,
  • Mariagrazia Nizzola,
  • Pietro Familiari,
  • Marco Giugliano,
  • Anthony Kevin Scafa,
  • Santi Galletta,
  • Xiaobo Li and
  • Antonio Santoro
  • + 2 authors

9 February 2020

Glioblastoma is a solid, infiltrating, and the most frequent highly malignant primary brain tumor. Our aim was to find the correlation between sex, age, preoperative Karnofsky performance status (KPS), presenting with seizures, and extent of resectio...

  • Review
  • Open Access
15 Citations
4,332 Views
15 Pages

28 July 2021

Telomere maintenance plays important roles in genome stability and cell proliferation. Tumor cells acquire replicative immortality by activating a telomere-maintenance mechanism (TMM), either telomerase, a reverse transcriptase, or the alternative le...

  • Article
  • Open Access
23 Citations
5,341 Views
16 Pages

A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database

  • Amrit L. Pappula,
  • Shayaan Rasheed,
  • Golrokh Mirzaei,
  • Ruben C. Petreaca and
  • Renee A. Bouley

26 August 2021

Gliomas are differentiated into two major disease subtypes, astrocytoma or oligodendroglioma, which are then characterized as either IDH (isocitrate dehydrogenase)-wild type or IDH-mutant due to the dramatic differences in prognosis and overall survi...

  • Review
  • Open Access
67 Citations
9,911 Views
32 Pages

ALT Positivity in Human Cancers: Prevalence and Clinical Insights

  • Danny MacKenzie,
  • Andrea K. Watters,
  • Julie T. To,
  • Melody W. Young,
  • Jonathan Muratori,
  • Marni H. Wilkoff,
  • Rita G. Abraham,
  • Maria M. Plummer and
  • Dong Zhang

14 May 2021

Many exciting advances in cancer-related telomere biology have been made in the past decade. Of these recent advances, great progress has also been made with respect to the Alternative Lengthening of Telomeres (ALT) pathway. Along with a better under...

  • Review
  • Open Access
31 Citations
7,695 Views
26 Pages

Epigenetic Factors that Control Pericentric Heterochromatin Organization in Mammals

  • Salvatore Fioriniello,
  • Domenico Marano,
  • Francesca Fiorillo,
  • Maurizio D’Esposito and
  • Floriana Della Ragione

28 May 2020

Pericentric heterochromatin (PCH) is a particular form of constitutive heterochromatin that is localized to both sides of centromeres and that forms silent compartments enriched in repressive marks. These genomic regions contain species-specific repe...

  • Article
  • Open Access
75 Citations
5,160 Views
10 Pages

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile

  • Annalisa Astolfi,
  • Margherita Nannini,
  • Valentina Indio,
  • Angela Schipani,
  • Alessandro Rizzo,
  • Anna Myriam Perrone,
  • Pierandrea De Iaco,
  • Maria Giulia Pirini,
  • Antonio De Leo and
  • Maria Abbondanza Pantaleo
  • + 1 author

31 July 2020

Uterine Leiomyosarcoma (uLMS) is by far the most common type of uterine sarcoma, characterized by an aggressive clinical course, a heterogeneous genetic profile and a very scarce response to cytotoxic chemotherapy. The genetic make-up of uLMS is an a...

  • Article
  • Open Access
6 Citations
2,973 Views
12 Pages

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)

  • Giuseppe Lamberti,
  • Natalie Prinzi,
  • Alberto Bongiovanni,
  • Mariangela Torniai,
  • Elisa Andrini,
  • Dario de Biase,
  • Deborah Malvi,
  • Mirta Mosca,
  • Rossana Berardi and
  • Davide Campana
  • + 1 author

Background: Grade 3 gastro-entero-pancreatic neuroendocrine tumors (G3 GEP-NET) are poorly characterized in terms of molecular features and response to treatments. Methods: Patients with G3 GEP-NET were included if they received capecitabine and temo...

  • Review
  • Open Access
9 Citations
5,690 Views
27 Pages

12 November 2021

Despite their low incidence, pediatric high-grade gliomas (pHGGs), including diffuse intrinsic pontine gliomas (DIPGs), are the leading cause of mortality in pediatric neuro-oncology. Recurrent, mutually exclusive mutations affecting K27 (K27M) and G...

  • Article
  • Open Access
1 Citations
3,590 Views
12 Pages

25 March 2020

While loss-of-function mutations in the ATRX gene have been implicated as a driving force for a variety of pediatric brain tumors, as well as pancreatic neuroendocrine tumors, the role of ATRX in gene regulation and oncogenic development is not well-...

  • Review
  • Open Access
27 Citations
6,686 Views
16 Pages

7 September 2019

Herpesviruses are important pathogens that can cause significant morbidity and mortality in the human population. Herpesviruses have a double-stranded DNA genome, and viral genome replication takes place inside the nucleus. Upon entering the nucleus,...

  • Review
  • Open Access
28 Citations
8,465 Views
24 Pages

Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities

  • Santiago Haase,
  • Fernando M. Nuñez,
  • Jessica C. Gauss,
  • Sarah Thompson,
  • Emily Brumley,
  • Pedro Lowenstein and
  • Maria G. Castro

17 December 2020

In this review, we discuss the molecular characteristics, development, evolution, and therapeutic perspectives for pediatric high-grade glioma (pHGG) arising in cerebral hemispheres. Recently, the understanding of biology of pHGG experienced a revolu...

  • Review
  • Open Access
13 Citations
4,870 Views
13 Pages

29 October 2021

The study of the molecular pathways underlying cancer has given us important insights into how breaks in our DNA are repaired and the dire consequences that can occur when these processes are perturbed. Extensive research over the past 20 years has s...

  • Article
  • Open Access
1 Citations
2,369 Views
11 Pages

Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis

  • Miguel Mayol del Valle,
  • Bryan Morales,
  • Brandon Philbrick,
  • Segun Adeagbo,
  • Subir Goyal,
  • Sarah Newman,
  • Natasha L. Frontera,
  • Edjah Nduom,
  • Jeffrey Olson and
  • Kimberly Hoang

18 January 2024

Intramedullary spinal cord tumors (IMSCTs) harbor unique genetic mutations which may play a role in prognostication and management. To this end, we present the largest cohort of IMSCTs with genetic characterization in the literature from our multi-si...

  • Review
  • Open Access
32 Citations
6,641 Views
22 Pages

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets

  • Ahmad Ozair,
  • Vivek Bhat,
  • Reid S. Alisch,
  • Atulya A. Khosla,
  • Rupesh R. Kotecha,
  • Yazmin Odia,
  • Michael W. McDermott and
  • Manmeet S. Ahluwalia

20 February 2023

Gliomas, the most common type of malignant primary brain tumor, were conventionally classified through WHO Grades I–IV (now 1–4), with low-grade gliomas being entities belonging to Grades 1 or 2. While the focus of the WHO Classification...

  • Systematic Review
  • Open Access
7,716 Views
13 Pages

Gastrointestinal Pathologies Associated with Thalassemia: A Systematic Review

  • Sara Fakeh,
  • Ahmad Masoud,
  • Raneem Abuqtaish,
  • Bayan Salman,
  • Layth Al-Ramahi,
  • Omar AlWahkyan and
  • Dua Abuquteish

Background/Objectives: Thalassemia, a hereditary blood disorder, leads to reduced hemoglobin levels, impairing oxygen transport and negatively impacting patient health. Recent research suggests a possible association between thalassemia and gastroint...

  • Article
  • Open Access
5 Citations
3,161 Views
15 Pages

Transcriptomic Landscape of Lower Grade Glioma Based on Age-Related Non-Silent Somatic Mutations

  • YoungJoon Park,
  • JeongMan Park,
  • Ju Won Ahn,
  • Jeong Min Sim,
  • Su Jung Kang,
  • Suwan Kim,
  • So Jung Hwang,
  • Song-Hee Han,
  • Kyoung Su Sung and
  • Jaejoon Lim

19 June 2021

Glioma accounts for 80% of all malignant brain tumours and is the most common adult primary brain tumour. Age is an important factor affecting the development of cancer, as somatic mutations accumulate with age. Here, we aimed to analyse the signific...

  • Communication
  • Open Access
3 Citations
2,440 Views
9 Pages

A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience

  • Wen-Hsuan Tsai,
  • Shuen-Han Dai,
  • Chun-Chuan Lee,
  • Ming-Nan Chien and
  • Yi-Hong Zeng

8 April 2023

Background: There is limited information regarding the immunohistochemistry stain and its prognostic role in adrenocortical carcinoma (ACC), and few studies focus on Asian patients. Our study aims to identify the correlation between immunohistochemis...

of 3